ZYME Financials
Zymeworks Inc. Common Stock - Financial statements & key metrics
Stock Price
$30.40
Market Cap
$1.68B
P/E Ratio
-18.8
EPS
$-1.62
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$76.30M
Gross Profit
-
Operating Income
-
Net Income
$-122.69M
EPS (Diluted)
$-1.62
Balance Sheet Highlights
Total Assets
$463.09M
Total Liabilities
$124.32M
Shareholders Equity
-
Cash & Equivalents
$66.10M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-110.04M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-126.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ZYME revenue?
ZYME's most recent quarterly revenue was $76.30M. Annual revenue can be calculated by summing the four most recent quarters.
Is ZYME profitable?
ZYME reported a loss of $122.69M in the most recent quarter. The net profit margin is -126.3%.
What is ZYME market cap?
ZYME has a market capitalization of $1.68B, making it a small-cap stock.
Does ZYME have debt?
View ZYME's balance sheet for debt information.
What is ZYME cash flow?
Cash flow data is available in the full financial statements.